GlassScriptPhysician profile
Meena M Aserlind
NPI 1619395332
$1,292.93
in general payments reported to CMS, 2019-2025
20 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.29 · 2020: $141 · 2021: $239 · 2022: $187 · 2023: $73.92 · 2024: $327 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $217.57 | 2019-2023 | |
| Medical Device Business Services, INC. | $173.89 | 2021-2022 | |
| Novo Nordisk INC | $148.06 | 2022-2025 | Wegovy |
| Organon LLC | $116.03 | 2021-2024 | Nexplanon |
| Mayne Pharma Commercial LLC | $91.95 | 2025 | |
| Coloplast Corp | $69.23 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $65.93 | 2019-2021 | |
| Exeltis, USA INC. | $62.74 | 2020-2024 | Slynd |
| Biogen, INC. | $52.27 | 2024-2025 | Zurzuvae |
| Evofem Biosciences, INC. | $51.69 | 2024-2025 | Phexxi, Solosec, Phexx |
| Abbvie INC. | $41.69 | 2020-2023 | Vraylar |
| Boston Scientific Corporation | $36.47 | 2025 | Axonics |
| Hologic Sales and Service, LLC | $29.53 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $26.72 | 2024 | Myfembree |
| Agile Therapeutics, INC. | $24.95 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $24.48 | 2024 | Zepbound |
| Astellas Pharma US INC | $24.44 | 2024 | Veozah |
| Shield Therapeutics INC | $20.31 | 2024 | |
| Aspira Women'S Health INC | $11.62 | 2024 | Ova1 |
| Acacia Pharma INC | $3.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meena Aserlind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.